Literature DB >> 16332361

Standardization of calibration and quality control using surface enhanced laser desorption ionization-time of flight-mass spectrometry.

Judith A P Bons1, Douwe de Boer, Marja P van Dieijen-Visser, Will K W H Wodzig.   

Abstract

BACKGROUND: Protein profiling by surface enhanced laser desorption ionization-time of flight-mass spectrometry (SELDI-TOF-MS) is gaining importance as a diagnostic tool for a whole range of diseases. This report describes a QC procedure, which acts prospectively by checking the calibration before starting profiling experiments.
METHODS: A well-defined protocol for calibration of the Protein Biosystem IIc instrument was established, using a commercial QC sample containing independent certified standards and by determination of acceptance criteria. Instrument calibration was performed externally every week with the standards provided by the manufacturer. QC was performed for the period of 5 months.
RESULTS: According to the acceptance criteria defined in this study, data points should be in the established range of the process mean+/-2 standard deviations for the mass-to-charge ratios (m/z values), peak intensities, signal-to-noise ratios (S/N), and peak resolutions for insulin and apomyoglobin in the QC sample. Moreover, it was demonstrated that the pipetting variability in the handling of the QC sample significantly contributed to systematic errors and that spotting of a larger volume of QC sample resulted in a better reproducibility.
CONCLUSIONS: Stringent quality control of the calibration part of SELDI-TOF-MS experiments prevents unreliable data acquisition from the very start.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16332361     DOI: 10.1016/j.cca.2005.10.019

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling.

Authors:  Simone Nicolardi; Magnus Palmblad; Hans Dalebout; Marco Bladergroen; Rob A E M Tollenaar; André M Deelder; Yuri E M van der Burgt
Journal:  J Am Soc Mass Spectrom       Date:  2010-05-12       Impact factor: 3.109

Review 2.  Mass spectrometry based proteomics in urine biomarker discovery.

Authors:  Dan Theodorescu; Harald Mischak
Journal:  World J Urol       Date:  2007-08-17       Impact factor: 4.226

3.  High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine.

Authors:  Harald Mischak; Bruce A Julian; Jan Novak
Journal:  Proteomics Clin Appl       Date:  2007-07-10       Impact factor: 3.494

4.  Longitudinal analysis of maternal plasma apolipoproteins in pregnancy: a targeted proteomics approach.

Authors:  Shannon K Flood-Nichols; Deborah Tinnemore; Mark A Wingerd; Ali I Abu-Alya; Peter G Napolitano; Jonathan D Stallings; Danielle L Ippolito
Journal:  Mol Cell Proteomics       Date:  2012-10-10       Impact factor: 5.911

5.  Current literature in mass spectrometry.

Authors: 
Journal:  J Mass Spectrom       Date:  2007-01       Impact factor: 1.982

6.  Integrated multi-level quality control for proteomic profiling studies using mass spectrometry.

Authors:  David A Cairns; David N Perkins; Anthea J Stanley; Douglas Thompson; Jennifer H Barrett; Peter J Selby; Rosamonde E Banks
Journal:  BMC Bioinformatics       Date:  2008-12-04       Impact factor: 3.169

7.  Laboratory methods to improve SELDI peak detection and quantitation.

Authors:  Dominique Rollin; Toni Whistler; Suzanne D Vernon
Journal:  Proteome Sci       Date:  2007-07-02       Impact factor: 2.480

8.  A method for improving SELDI-TOF mass spectrometry data quality.

Authors:  Toni Whistler; Dominique Rollin; Suzanne D Vernon
Journal:  Proteome Sci       Date:  2007-09-05       Impact factor: 2.480

Review 9.  Computational methods for protein identification from mass spectrometry data.

Authors:  Leo McHugh; Jonathan W Arthur
Journal:  PLoS Comput Biol       Date:  2008-02       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.